Inventor · disambiguated record
Dennis John Underwood
Also filed as: MORAN MAGDALENE M · UNDERWOOD DENNIS · UNDERWOOD DENNIS J · UNDERWOOD DENNIS JOHN
30 granted patents·25 pending applications·242 citations·filing 1982–2025
97Inventor score
Top patents by PatentIndex Score
55 records- 0197US10912831B1Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 9, 2021·6 cites·26 claims
- 0297US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0396US11638755B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted May 2, 2023·4 cites·20 claims
- 0496US10639368B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2017·Granted May 5, 2020·15 cites·32 claims
- 0595US10912828B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 9, 2021·4 cites·36 claims
- 0694US11242385B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Feb 8, 2022·8 cites·24 claims
- 0794US5387595AAlicyclic compounds as tachykinin receptor antagonistsMERCK & CO INC·Filed 1992·Granted Feb 7, 1995·72 cites·8 claims
- 0893US11013802B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2017·Granted May 25, 2021·5 cites·21 claims
- 0992US7893260B2Substituted quinazolin-4-one compounds for antagonizing TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Feb 22, 2011·23 cites·13 claims
- 1091US7998980B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2007·Granted Aug 16, 2011·15 cites·10 claims
- 1189US7803790B2Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2006·Granted Sep 28, 2010·12 cites·10 claims
- 1288US10800849B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Oct 13, 2020·2 cites·26 claims
- 1387US10577426B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Mar 3, 2020·3 cites·21 claims
- 1485US12246066B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2023·Granted Mar 11, 2025·0 cites·19 claims
- 1585US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 1685US4650792AMosquito abatementUNDERWOOD DENNIS·Filed 1982·Granted Mar 17, 1987·25 cites·18 claims
- 1784US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 1884US9181219B2Compounds of modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2013·Granted Nov 10, 2015·5 cites·5 claims
- 1983US11021537B2Anti-TIGIT antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Jun 1, 2021·2 cites·70 claims
- 2082US8916550B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2006·Granted Dec 23, 2014·3 cites·26 claims
- 2182US2023039577A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 2282US2024181048A1Anti-tim-3 antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 2381US8389546B2Compounds for modulating TRPV3 functionMORAN MAGDALENE M·Filed 2011·Granted Mar 5, 2013·4 cites·14 claims
- 2480US11359028B2Anti-OX40 antibodies and anti-GITR antibodiesAGENUS INC·Filed 2019·Granted Jun 14, 2022·1 cites·16 claims
- 2580US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 2680US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 2778US12492393B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Granted Dec 9, 2025·0 cites·28 claims
- 2878US2024141047A1Anti-tigit antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 2975US12011481B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2021·Granted Jun 18, 2024·0 cites·28 claims
- 3075US2025360209A1Anti-ctla-4 antibodies and methods of use thereofAGENUS INC·Filed 2025·Application pending·0 cites
- 3174US11098117B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 24, 2021·0 cites·25 claims
- 3274US9486455B2Compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Nov 8, 2016·2 cites·13 claims
- 3374US8552009B2Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 functionCHONG JAYHONG A·Filed 2011·Granted Oct 8, 2013·2 cites·14 claims
- 3474US2022106581A1Anti-cd137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 3573US11401335B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 2, 2022·0 cites·16 claims
- 3673US2022389107A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 3773US2022380479A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 3872US2021171648A1Antibodies and methods of use thereofAGENUS INC·Filed 2020·Application pending·0 cites
- 3971US11839653B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Dec 12, 2023·0 cites·25 claims
- 4065US2022089732A1Anti-tigit antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 4164US2015299225A1Compounds for modulating trpv3 functionCHONG JAYHONG A·Filed 2014·Application pending·0 cites
- 4261US2009018147A1Compounds for modulating TRPV3 functionHYDRA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 4357US2022257733A1Antigenic polypeptides and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 4456US2014155417A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 4554US2023301905A1Inhalable therapeutic agentsCILA THERAPEUTIC INC·Filed 2021·Application pending·0 cites
- 4653US2016256447A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 4751US2017224687A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 4850US2017020858A1Compounds for modulating trpv3 functionHYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 4948US2010273777A1Compounds for Modulating TRPV3 FunctionHYDRA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 5047US2022117893A1Inhalable therapeutic agentTHE BLUE GROUP LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dennis John Underwood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →